Aesculus Bio ApS: Financial statements 2020
CVR: 40560866
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Aesculus Bio ApS (CVR 40560866) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -11,740 and a net result of DKK -14,631. Equity in the 2020 report amounted to DKK 93,065. The solvency ratio was 45%.
- Gross Profit
- DKK -11,740
- Profit/Loss
- DKK -14,631
- Equity
- DKK 93,065
- Total Assets
- DKK 206,982
Official annual report
How creditworthy is Aesculus Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Aesculus Bio ApS has published its interim report for the period May 14, 2019 – December 31, 2019.
As of April 18, 2020, PN INVESTMENT ApS is registered as an owner of Aesculus Bio ApS with an ownership share of 33%.
About Aesculus Bio ApS
Aesculus Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Benjamin Anderschou Holbech Jensen. The board consists of Peter Hviid Nordkild (chair) and Benjamin Anderschou Holbech Jensen. The company is owned by Benjamin Anderschou Holbech Jensen, PN INVESTMENT ApS and Jan Wehkamp. In 2025, the company reported a gross profit of DKK -154,862 and a net result of DKK -129,437 compared with DKK -45,866 the year before. Equity in the 2025 report amounted to DKK -34,097.